You are viewing: US ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The US ECMO Machines Market was valued at $117.14 Million in 2025 and projected to reach to $160.69 Million by 2030, representing a compound annual growth rate of 6.5%. The US ECMO machines market is positioned for sustained growth through 2030, driven by increasing prevalence of cardiac and respiratory complications, expanding critical care capacity, and technological advancements in extracorporeal membrane oxygenation systems.

US ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US ECMO Machines Market Trends and Insights

  • The US market is driven by increasing adoption of extracorporeal membrane oxygenation technology in critical care settings, rising prevalence of cardiac and respiratory failures, and growing investment in advanced life support infrastructure across US hospitals.
  • The US healthcare system's emphasis on innovative treatment modalities and reimbursement support for ECMO procedures continues to strengthen market expansion. In the US, the ECMO machines market benefits from a well-established healthcare infrastructure, high patient awareness, and strong regulatory frameworks that facilitate rapid technology adoption.
  • The US market is characterized by significant competition among leading manufacturers and increasing clinical evidence supporting ECMO efficacy in treating severe cardiopulmonary conditions.
  • Between 2025 and 2030, the US is expected to maintain its position as a key growth market, supported by expanding ICU capacity, rising healthcare expenditure, and growing training programs for ECMO specialists across US medical institutions..

Key Market Statistics

  • CAGR (2025-2030) 6.5% CAGR
  • Market Size, 2025 ~USD 117.14 Million
  • Forecast, 2030 ~USD 160.69 Million
  • Country US

US ECMO Machines Market Overview

Market Valuation :

The US ECMO machines market is valued at $117.14 million in 2025, with strong growth trajectory reaching $160.69 million by 2030, representing a 6.5% CAGR.

Critical Care Adoption :

US hospitals are increasingly adopting ECMO technology in intensive care units, driven by rising cases of cardiac and respiratory failures requiring advanced life support interventions.

Healthcare Infrastructure Investment :

Growing capital investment in advanced life support infrastructure across US hospitals and specialized cardiac centers is accelerating ECMO machine deployment and utilization rates.

Outpacing Global Growth :

The US market CAGR of 6.5% exceeds the global average of 5.8%, indicating stronger regional demand and favorable reimbursement policies supporting market expansion.

US ECMO Machines Market Dynamics

  • Healthcare providers are prioritizing ECMO technology adoption to improve patient outcomes in life-threatening conditions, supported by favorable Medicare and private insurance reimbursement frameworks.
  • The market will benefit from growing awareness among clinicians, enhanced training programs, and integration of ECMO services in major medical centers across the country..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US ECMO machines market is valued at $117.14 million in 2025 and is forecast to reach $160.69 million by 2030, representing a 6.5% CAGR.
    • The US market growth is driven by increasing adoption in critical care, rising cardiac and respiratory failure cases, and strong healthcare infrastructure investment.
    • The US benefits from robust reimbursement policies, advanced regulatory frameworks, and high clinical adoption rates that accelerate market expansion.
    • The US market is expected to maintain leadership through 2030 due to expanding ICU capacity, rising healthcare spending, and growing ECMO specialist training programs.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    US ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    US: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS32.1533.5835.1536.8238.6740.6942.8945.35.2
    HOSPITALS120.46127.04134.25141.99150.58159.98170.27181.546.2
    SPECIALTY CLINICS21.5622.3123.1324.0124.9826.0427.1928.454.2
    TOTAL174.17182.93192.53202.81214.23226.71240.36255.295.8

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need US market data to assess market size, competitive positioning, pricing strategies, and growth opportunities in the world's largest healthcare market.
    • Hospital Administrators : Healthcare facility leaders require market insights to justify ECMO program investments, benchmark utilization rates against peers, and plan critical care infrastructure expansion.
    • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities need US-specific market forecasts, growth drivers, and financial projections to assess portfolio companies and acquisition targets.
    • Clinical & Research Institutions : Academic medical centers and research organizations need market data to understand adoption trends, identify funding opportunities, and guide clinical program development strategies.
    • Healthcare Consultants & Analysts : Consulting firms and market analysts require detailed US market segmentation, competitive analysis, and trend forecasting to support client strategy development and market advisory services.

    Key Companies in the US ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • US-Specific Market Sizing : Obtain precise valuation data for the US ECMO market with verified 2025 baseline ($117.14M) and 2030 forecast ($160.69M), enabling accurate budget allocation and revenue projections.
    • Regional Growth Dynamics : Understand US market drivers including hospital infrastructure investments, reimbursement policies, and adoption rates that differ from global trends, with 6.5% CAGR outpacing worldwide growth.
    • Competitive Landscape Intelligence : Identify key players, market share distribution, and competitive strategies specific to the US healthcare system, including FDA approvals and regulatory pathways affecting market entry.
    • Strategic Investment Guidance : Make informed decisions on market entry, expansion, or partnership opportunities in the US ECMO sector with comprehensive analysis of demand drivers and growth opportunities through 2030.
    • Stakeholder Benchmarking : Compare performance metrics against US market benchmarks, identify emerging trends in critical care adoption, and align product development with regional clinical and operational requirements.

    Frequently asked questions

    What is the current size of the US ECMO machines market in 2025?

    The US ECMO machines market is valued at $117.14 million in 2025, reflecting strong adoption of extracorporeal membrane oxygenation technology across US healthcare facilities.

    What is the projected market size for ECMO machines in the US by 2030?

    The US ECMO machines market is projected to reach $160.69 million by 2030, growing at a compound annual growth rate of 6.5% from 2025 to 2030.

    What factors are driving growth in the US ECMO machines market?

    The US market is driven by increasing prevalence of cardiac and respiratory failures, rising adoption in critical care settings, strong reimbursement support, and expanding ICU infrastructure across US hospitals.

    How does the US ECMO machines market compare to other regions?

    The US represents a mature and well-established market with advanced healthcare infrastructure, strong regulatory frameworks, and high clinical adoption rates that position it as a leading global market for ECMO technology.

    What are the key challenges in the US ECMO machines market?

    Key challenges in the US market include high equipment costs, need for specialized training and expertise, limited availability of ECMO specialists in certain regions, and stringent regulatory requirements for device approval and clinical use.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status